Clinical practice The management of hyperammonemia

被引:79
|
作者
Haeberle, Johannes [1 ]
机构
[1] Univ Childrens Hosp Zurich, Div Metab, Kinderspital Zurich, CH-8032 Zurich, Switzerland
关键词
Ammonia; Glutamine; Urea cycle; Nitrogen metabolism; Awareness; Neurotoxicity; Cerebral edema; UREA-CYCLE DISORDERS; ORNITHINE TRANSCARBAMYLASE DEFICIENCY; ALTERNATIVE PATHWAY THERAPY; PORTAL-SYSTEMIC ENCEPHALOPATHY; AMINO-ACID-METABOLISM; NITROGEN-METABOLISM; AMMONIA TOXICITY; NEONATAL HYPERAMMONEMIA; NUTRITIONAL MANAGEMENT; HEPATIC-ENCEPHALOPATHY;
D O I
10.1007/s00431-010-1369-2
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Hyperammonemia is a life-threatening condition which can affect patients at any age. Elevations of ammonia in plasma indicate its increased production and/or decreased detoxification. The hepatic urea cycle is the main pathway to detoxify ammonia; it can be defective due to an inherited enzyme deficiency or secondary to accumulated toxic metabolites or substrate depletion. Clinical signs and symptoms in hyperammonemia are unspecific but they are mostly neurological. Thus, in any unexplained change in consciousness or in any unexplained encephalopathy, hyperammonemia must be excluded as fast as possible. Any delay in recognition and start of treatment of hyperammonemia may have deleterious consequences for the patient. Treatment largely depends on the underlying cause but is, at least in pediatric patients, mainly aimed at establishing anabolism to avoid endogenous protein breakdown and amino acid imbalances. In addition, pharmacological treatment options exist to improve urea cycle function or to remove nitrogen, but their use depend on the underlying disorder. To improve the prognosis of acute hyperammonemia, an increased awareness of this condition is probably more needed than anything else. Likewise, the immediate start of appropriate therapy is of utmost importance. This review focuses on a better understanding of factors leading to ammonia elevations and on practical aspects related to diagnosis and treatment in order to improve clinical management of hyperammonemia.
引用
收藏
页码:21 / 34
页数:14
相关论文
共 50 条
  • [21] Diagnosis and Management of Hyperammonemia in Newborns: Is It Still a Challenge?
    Ersoy, Melike
    Salihoglu, Ozgul
    Cetin, Tugce
    IRANIAN JOURNAL OF NEONATOLOGY, 2021, 12 (03) : 40 - 47
  • [22] Hyperammonemia in the ICU
    Clay, Alison S.
    Hainline, Bryan E.
    CHEST, 2007, 132 (04) : 1368 - 1378
  • [23] Perioperative Exacerbation of Valproic Acid-Associated Hyperammonemia: A Clinical and Genetic Analysis
    Bezinover, Dmitri
    Postula, Marek
    Donahue, Kathleen
    Bentzen, Brian
    McInerney, James
    Janicki, Piotr K.
    ANESTHESIA AND ANALGESIA, 2011, 113 (04): : 858 - 861
  • [24] Establishment of hyperammonemia mode in yellow catfish and the mitigation of exogenous L-ornithine-L-aspartate
    Zhang, Muzi
    Fan, Yuwen
    Jiang, Haibo
    Shao, Jian
    Li, Ming
    DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 2022, 135
  • [25] Clinical aspects of urea cycle dysfunction and altered brain energy metabolism on modulation of glutamate receptors and transporters in acute and chronic hyperammonemia
    Natesan, Vijayakumar
    Mani, Renuka
    Arumugam, Ramakrishnan
    BIOMEDICINE & PHARMACOTHERAPY, 2016, 81 : 192 - 202
  • [26] Urea cycle defects and hyperammonemia: effects on functional imaging
    Gropman, Andrea L.
    Prust, Morgan
    Breeden, Andrew
    Fricke, Stanley
    VanMeter, John
    METABOLIC BRAIN DISEASE, 2013, 28 (02) : 269 - 275
  • [27] Serum Ammonia in Cirrhosis: Clinical Impact of Hyperammonemia, Utility of Testing, and National Testing Trends
    Deutsch-Link, Sasha
    Moon, Andrew M.
    Jiang, Yue
    Barritt, A. Sidney
    Tapper, Elliot B.
    CLINICAL THERAPEUTICS, 2022, 44 (03) : E45 - E57
  • [28] Characteristics and outcomes of critically ill patients with severe hyperammonemia
    Jacoby, Katherine J.
    Singh, Parvati
    Prekker, Matthew E.
    Leatherman, James W.
    JOURNAL OF CRITICAL CARE, 2020, 56 : 177 - 181
  • [29] Effect of zinc on liver cirrhosis with hyperammonemia: A preliminary randomized, placebo-controlled double-blind trial
    Katayama, Kazuhiro
    Saito, Masanori
    Kawaguchi, Takumi
    Endo, Ryujin
    Sawara, Kei
    Nishiguchi, Shuhei
    Kato, Akinobu
    Kohgo, Hiroshi
    Suzuki, Kazutomo
    Sakaida, Isao
    Ueno, Yoshiyuki
    Habu, Daiki
    Ito, Toshifumi
    Moriwaki, Hisataka
    Suzuki, Kazuyuki
    NUTRITION, 2014, 30 (11-12) : 1409 - 1414
  • [30] Hyperammonemia in Hepatic Encephalopathy
    Jayakumar, A. R.
    Norenberg, Michael D.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2018, 8 (03) : 272 - 280